MENU
FEB 23, 2022 Opens: 6:00 AM PST

Drug Discovery & Development 2022



Labroots and the Drug Discovery planning committee are pleased to announce the 5th Annual Drug Discovery & Development Virtual Conference. Labroots will host this online-only event on February 23, 2022. The Drug Discovery planning committee will invite speakers from industry and academia to discuss key challenges, new opportunities, and recent successes in the current landscape of drug discovery and development.

The tracks include:
  • Novel Approaches to Drug Discovery and Preclinical Development
    • Emerging Assays
    • Novel Models in Drug Discovery
    • Rational Drug Design
    • MAb Conjugations
    • Aptamers
  • Explorations into PK/PD and Pharmacogenomics
    • PGX of GPCRs
    • In-vitro Models of Toxicity
  • Advancements in Clinical Development
    • ​​​​​​​Health Equality and Genetic Diversity in Clinical Trials
    • Innovations in Biomarkers
    • Digital Solutions
    • Proteomics

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2022 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Use #LRdrug to follow the conversation!


Speakers
  • Esperanza Anguiano, PhD, MS-MBA

    Scientific Market Development Director of BioPharma, Nanostring
    BIOGRAPHY
  • Hilal Arnouk, MD, PhD

    Associate Professor, Dept. of Pathology, Midwestern University
    BIOGRAPHY
  • Fergus Fleming

    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC
    BIOGRAPHY
  • Christina Gonzalez

    Project Manager, Pathology, ICON Central Laboratories
    BIOGRAPHY
  • Alexander Sebastian Hauser, PhD

    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen
    BIOGRAPHY
  • Michael Johnson, PhD

    CEO and Co-Founder, Visikol
    BIOGRAPHY
  • Ines Liebscher, PhD

    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry
    BIOGRAPHY
  • Michelle Longmire, MD

    CEO & Co-founder, Medable
    BIOGRAPHY
  • Debbie Marshall

    Program Manager
    BIOGRAPHY
  • Paul McCracken, PhD

    Vice President, Global Head of Medical Imaging, ICON
    BIOGRAPHY
  • James McKim, PhD

    President and CEO, IONTOX
    BIOGRAPHY
  • Professor Kevin Pfleger, MA, PhD, FBPhS

    Director Biomedical Innovation, The University of Western Australia, Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research
    BIOGRAPHY
  • Nikolina Radulovich, PhD

    Staff Scientist, Princess Margaret Hospital in Toronto
    BIOGRAPHY
  • Stacey Ward, PhD

    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
    BIOGRAPHY

Show Resources
You May Also Like
NOV 09, 2022 6:00 AM PST
NOV 09, 2022 6:00 AM PST
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
SEP 06, 2022 6:00 AM PDT
SEP 06, 2022 6:00 AM PDT
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
MAR 23, 2022 6:00 AM PDT
C.E. CREDITS
MAR 23, 2022 6:00 AM PDT
LabRoots is pleased to announce the 5th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 23, 2022. The Cannabis Sciences planning committee will be plannin...
MAY 04, 2022 5:30 AM PDT
C.E. CREDITS
MAY 04, 2022 5:30 AM PDT
A novel coronavirus emerged in China in late 2019; it has since been dubbed 2019-nCoV. Labroots will be working to educate the community about this...
MAY 18, 2022 6:00 AM PDT
MAY 18, 2022 6:00 AM PDT
Welcome to the 6th Annual Laboratory Automation Virtual Event ; a free virtual conference for professionals interested in the most recent technologies for today’s labs. Lab automation...
APR 19, 2022 6:00 AM PDT
APR 19, 2022 6:00 AM PDT
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
Agenda
Scheduled
  • Keynote Presentation: Profiling of Receptor Complexes using BRET
    FEB 23, 2022 7:30 AM PST
    Professor Kevin Pfleger, MA, PhD, FBPhS
    Director Biomedical Innovation, The University of Western Australia, Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Keynote Presentation: Engineering the Quantum Leap that Drug Development Needs
    FEB 23, 2022 9:00 AM PST
    Michelle Longmire, MD
    CEO & Co-founder, Medable
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • FEB 23, 2022 12:00 PM PST
    Paul McCracken, PhD, Debbie Marshall, Christina Gonzalez
    Paul McCracken, PhD
    Vice President, Global Head of Medical Imaging, ICON
    BIOGRAPHY
    Debbie Marshall
    Program Manager
    BIOGRAPHY
    Christina Gonzalez
    Project Manager, Pathology, ICON Central Laboratories
    BIOGRAPHY
  • Innovative Approaches to Biomarker Discovery in the Drug Development Process
    FEB 23, 2022 1:30 PM PST
    Esperanza Anguiano, PhD, MS-MBA
    Scientific Market Development Director of BioPharma, Nanostring
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • Genetically Engineered Custom Cell Lines for Pre-Clinical Research and Biomanufacturing
    FEB 23, 2022 3:00 PM PST
    Stacey Ward, PhD
    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
    BIOGRAPHY
    Sponsored By: MilliporeSigma
The following webinars will be readily on-demand when the event starts
  • Development and Characterization of an In Vitro Integrated Organ Platform for the Evaluation of Pharmacokinetic and Toxicologic Effects of Drugs and Chemicals
    James McKim, PhD
    President and CEO, IONTOX
    BIOGRAPHY
  • Enabling Translation of Biomarker Research to Clinical Practice
    Fergus Fleming
    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC
    BIOGRAPHY
  • How to Wake a Giant - Concepts of Adhesion GPCR Activation and their Potential Therapeutic Implications
    Ines Liebscher, PhD
    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry
    BIOGRAPHY
  • Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology
    Hilal Arnouk, MD, PhD
    Associate Professor, Dept. of Pathology, Midwestern University
    BIOGRAPHY
  • Identifying the Ideal In Vitro Liver Model for Various Research Applications
    Michael Johnson, PhD
    CEO and Co-Founder, Visikol
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Next Generation Biobanking of Patient-derived Organoid Models
    Nikolina Radulovich, PhD
    Staff Scientist, Princess Margaret Hospital in Toronto
    BIOGRAPHY
  • Personalised Medicine Through GPCR Pharmacogenomics
    Alexander Sebastian Hauser, PhD
    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen
    BIOGRAPHY
  • Novel Approaches to Drug Discovery and Preclinical Development
  • Keynote Presentation: Profiling of Receptor Complexes using BRET
    FEB 23, 2022 7:30 AM PST
    Professor Kevin Pfleger, MA, PhD, FBPhS
    Director Biomedical Innovation, The University of Western Australia, Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Genetically Engineered Custom Cell Lines for Pre-Clinical Research and Biomanufacturing
    FEB 23, 2022 3:00 PM PST
    Stacey Ward, PhD
    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
    BIOGRAPHY
    Sponsored By: MilliporeSigma
  • How to Wake a Giant - Concepts of Adhesion GPCR Activation and their Potential Therapeutic Implications
    Ines Liebscher, PhD
    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry
    BIOGRAPHY
  • Next Generation Biobanking of Patient-derived Organoid Models
    Nikolina Radulovich, PhD
    Staff Scientist, Princess Margaret Hospital in Toronto
    BIOGRAPHY
  • Identifying the Ideal In Vitro Liver Model for Various Research Applications
    Michael Johnson, PhD
    CEO and Co-Founder, Visikol
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Advancements in Clinical Development
  • Keynote Presentation: Engineering the Quantum Leap that Drug Development Needs
    FEB 23, 2022 9:00 AM PST
    Michelle Longmire, MD
    CEO & Co-founder, Medable
    BIOGRAPHY
    Continuing Education: P.A.C.E. CE | Florida CE
  • Innovations in Biomarkers
  • FEB 23, 2022 12:00 PM PST
    Paul McCracken, PhD, Debbie Marshall, Christina Gonzalez
    Paul McCracken, PhD
    Vice President, Global Head of Medical Imaging, ICON
    BIOGRAPHY
    Debbie Marshall
    Program Manager
    BIOGRAPHY
    Christina Gonzalez
    Project Manager, Pathology, ICON Central Laboratories
    BIOGRAPHY
  • Innovative Approaches to Biomarker Discovery in the Drug Development Process
    FEB 23, 2022 1:30 PM PST
    Esperanza Anguiano, PhD, MS-MBA
    Scientific Market Development Director of BioPharma, Nanostring
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • Identification of Novel Protein Biomarkers in the Era of Precision Medicine Oncology
    Hilal Arnouk, MD, PhD
    Associate Professor, Dept. of Pathology, Midwestern University
    BIOGRAPHY
  • Enabling Translation of Biomarker Research to Clinical Practice
    Fergus Fleming
    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC
    BIOGRAPHY
  • Explorations into PK/PD and Pharmacogenomics
  • Personalised Medicine Through GPCR Pharmacogenomics
    Alexander Sebastian Hauser, PhD
    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen
    BIOGRAPHY
  • Development and Characterization of an In Vitro Integrated Organ Platform for the Evaluation of Pharmacokinetic and Toxicologic Effects of Drugs and Chemicals
    James McKim, PhD
    President and CEO, IONTOX
    BIOGRAPHY
Speakers

  • Esperanza Anguiano, PhD, MS-MBA
    Esperanza Anguiano, PhD, MS-MBA
    Scientific Market Development Director of BioPharma, Nanostring
    BIOGRAPHY
  • Hilal Arnouk, MD, PhD
    Hilal Arnouk, MD, PhD
    Associate Professor, Dept. of Pathology, Midwestern University
    BIOGRAPHY
  • Fergus Fleming
    Fergus Fleming
    Co-Founder, Executive Director, Chief Technical Officer, Renalytix PLC
    BIOGRAPHY
  • Christina Gonzalez
    Christina Gonzalez
    Project Manager, Pathology, ICON Central Laboratories
    BIOGRAPHY
  • Alexander Sebastian Hauser, PhD
    Alexander Sebastian Hauser, PhD
    Assistant Professor, Department of Drug Design and Pharmacology, University of Copenhagen
    BIOGRAPHY
  • Michael Johnson, PhD
    Michael Johnson, PhD
    CEO and Co-Founder, Visikol
    BIOGRAPHY
  • Ines Liebscher, PhD
    Ines Liebscher, PhD
    Professor, Leipzig University, Rudolf-Schönheimer-Institute of Biochemistry
    BIOGRAPHY
  • Michelle Longmire, MD
    Michelle Longmire, MD
    CEO & Co-founder, Medable
    BIOGRAPHY
  • Debbie Marshall
    Debbie Marshall
    Program Manager
    BIOGRAPHY
  • Paul McCracken, PhD
    Paul McCracken, PhD
    Vice President, Global Head of Medical Imaging, ICON
    BIOGRAPHY
  • James McKim, PhD
    James McKim, PhD
    President and CEO, IONTOX
    BIOGRAPHY
  • Professor Kevin Pfleger, MA, PhD, FBPhS
    Professor Kevin Pfleger, MA, PhD, FBPhS
    Director Biomedical Innovation, The University of Western Australia, Head, Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research
    BIOGRAPHY
  • Nikolina Radulovich, PhD
    Nikolina Radulovich, PhD
    Staff Scientist, Princess Margaret Hospital in Toronto
    BIOGRAPHY
  • Stacey Ward, PhD
    Stacey Ward, PhD
    R&D Manager, Advanced Genetic and Cell Technologies, MilliporeSigma
    BIOGRAPHY
Sponsored by

For information on becoming a sponsor or exhibitor, please click here.


C.E. Credits

The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


Committee

To download the Program Committee brochure here.


  • Annette Gilchrist

    An Associate Professor with Midwestern University, Dr. Annette Gilchrist has a PhD in Immunology from the University of Connecticut Health Center and a MS in Biochemistry from the University of Connecticut. Previously, she was with Cue Biotech and Caden Biosciences, companies she ...

    See more See less
  • Matthew Flegal

    Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...

    See more See less
  • Martin Shaw

    Between 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as ...

    See more See less
  • Matthew Shipton

    Over the past 16 years, Mr. Shipton has amassed deep domain expertise in cell-based products and services. Currently serving as President of Novabiosis, Inc. Mr. Shipton brings a skill for implementing sales-driven business strategies, an extensive track record of meeting and ...

    See more See less
  • Professor Kevin Pfleger, MA, PhD, FBPhS

    Professor Pfleger is Director, Biomedical Innovation at The University of Western Australia (UWA) and the MTPConnect Western Australian Life Sciences Innovation Hub. He is also Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry ...

    See more See less
Help

Demographics

Loading Comments...
Show Resources
Event Countdown
  • 0 Days
  • 0 Hours
  • 0 Minutes
  • 0 Seconds